Children’s Cancer: The Tanzania Model and a Research Agenda for Africa
Declan Kirrane, Moderator, ISC Intelligence in Science
Barry Andrews Irish MEP, Brussels, Belgium
Sarah Maongezi Coordinator for Cancer, Non-communicable disease unit, Ministry of Health, Tanzania
Julius Mwaiselage Ocean Road Cancer Institute, Oncology, Tanzania
Adrian Fitzgerald Embassy of Ireland, Tanzania (TBC)
Trish Scanlan We are TLM (Tumaini la Maisha/Their Lives Matter)
11h25 Africa-European Partnerships
David Weakliam, ESTHER Alliance for Global Health Partnerships, Ireland
Joe Gannon Children Health Ireland (CHI) – Global, Ireland
Mary Horgan Royal College of Physicians of Ireland (RCPI), Ireland
Owen Smith University College Dublin UCD, Ireland
Martin Corbally Royal College of surgeons Ireland (RCSI)/Operation Child Life, Bahrain/Ireland
Rupert Handgretinger Children’s University Hospital & Tuebingen University, Germany
Moira Keogh Irish Blood Transfusion Service, Ireland
12h25 African Paediatric oncology networks
Joyce Balagadde Kambugu International Society of Paediatric oncology (SIOP), President Elect, Uganda
Sherif Kamal 57357 Hospital/Paediatric Oncology in Developing Countries PODC, (Onco-pharmacy Task Force), Egypt
Karim Assani Alliance Mondiale Contre le Cancer AMCC, Congo
Pierre Bey Groupe Franco Africain d’Oncologie Pediatrique, GFAOP, France
Joseph Lubega Global Hope/Baylor University/Texas Children’s Cancer Centre, United States
Nickhill Bhakta St Judes children’s research Hospital, United States
13h25 Paediatric Oncology Education & Clinical Innovation
Jeremie Hassan, Tumaini la Maisha
CLEVER CANCER CARE (Video), WeAreTLM group
Elizabeth Kelly ENCLUDE, Ireland
Hadija Mwamtemi Muhimbili National Hospital, MNH, Tanzania
Larry Akoko Muhimbili University of Health and Allied Sciences MUHAS & MNH, Tanzania
Sean Rooney Children’s Health Ireland-Crumlin, CHI, Ireland
Sikudhani Muya Ocean Road Cancer Institute ORCI, Tanzania
Lulu Chirande MUHAS, Tanzania
Liz Danik-Mtunga Kilimanjaro Christian Medical Centre, KCMC, Tanzania
Marie Jose Voeten Sengerema District Hospital, Tanzania
14h35 Tanzanian- European Research
Jonathan Bond University College Dublin, UCD, Ireland
Anne Jones Genuity Science, Ireland
Faraja Chiwanga Muhimbili National Hospital MNH, Tanzania
Farhat Khanim Birmingham/Warwick Universities, United Kingdom
Richard Bowman Retinoblastoma (RB) Network (Video), United Kingdom
Kristin Schroeder Duke University, Bugando Medical Centre, BMC, Tanzania, United States.
15h30 Key Donors
Fergal Fitzgerald ElectricAid, Ireland
Furaha Servanti Foundation for Cancer Care in Tanzania, FCCT, Tanzania
Josephine Njoroge DHL, Tanzania
Vivienne Mulema Clinton Health Access Initiative, CHAI, Uganda
Anne Magege ELMA Philanthropies, South Africa
Possible next Steps
Output paper and roadmap
Anne JonesChief Operating Officer, Genuity Science
Anne Jones brings over 25 years’ experience working in the life science, chemical analysis and diagnostics arenas, in Ireland, the UK and the USA, working across a broad range of markets, products and functions.
Prior to joining Genuity Science, Anne was Vice President and General Manager for Pall Corporations Lab, Food & Beverage business at US-based Danaher Corp. She also held senior roles in strategy development and planning at Agilent Technologies where she led business development and M&A activities for Agilent’s $2.3B Life Sciences and Applied Markets division and developed the strategy for Agilent’s successful entry into cell analysis. She also worked with Amersham Biosciences in the UK and GE Healthcare Life Sciences in the UK and USA in marketing and R&D roles.
A graduate of National University of Ireland, Galway, in Microbiology and Molecular Biology, Anne completed her PhD at Cancer Research UK, studying protein biochemistry and molecular biology with focus on human DNA repair where she isolated a critical protein and elucidated its function in DNA repair, publishing this work in the highly-cited journals, ‘Nature’ and ‘J Biol. Chem’. Anne was recently recognized as one of The Top 25 Women Leaders in Biotechnology of 2020 by the The Healthcare Technology Report.
David Weakliam Director of the HSE Global Health Programme and a Specialist in Public Health MedicineDavid WeakliamDirector of the HSE Global Health Programme and a Specialist in Public Health Medicine
Dr David Weakliam is Director of the HSE Global Health Programme and a Specialist in Public Health Medicine. He has worked in global health for more than thirty years, including twelve years in Nepal, Liberia, Sudan, DR Congo and Ghana. From 2003 to 2007 he was Health Advisor with Irish Aid, the Government’s overseas aid programme. David has been leading the HSE Global Health Programme since it was established in 2010. He manages bilateral programmes with Ministries of Health in Mozambique, Ethiopia, Sudan and Zambia. He leads the ESTHER Ireland Programme which supports health personnel to develop links with low and middle income countries. He is Adjunct Professor in global health at University College Dublin.
Declan Kirrane Director ISC Intelligence in Science and Coordinator EU Africa Radio Astronomy PlatformDeclan KirraneDirector ISC Intelligence in Science and Coordinator EU Africa Radio Astronomy Platform
Declan Kirrane is Managing Director of ISC Intelligence in Science, a specialized science, technology and R&D public affairs firm based in Brussels, Belgium. ISC develops and implements Strategic Research Agendas for science and technology-based organisations in the EU and US.
His practice areas cover IP, R&D consortia development, management and dissemination and is responsible for themes of ICT, health, security, defence, space and related policies, legislation, programmes and funding mechanisms. Declan Kirrane has a background in analysing the relationship between public and private R&D funding and the impact on R&D performance: he has worked extensively on science and technology policy evaluation methodologies and technology options for policy- and decision-makers. The EU’s Digital Agenda, emerging European space, security and defence policies are part of his remit.
Hadija MwamtemiConsultant Paediatric Haematologist and Oncologist
Dr. Hadija Mwamtemi is a senior medical specialist at Muhimbili National Hospital in the department of Paediatrics and Child Health. She obtained her MD degree (1988) In the University of Havana Cuba Calxito (Garcia Hospital). In 1993 she was enrolled in masters programme of Paediatrics in Muhimbili University Collage of Health sciences, in 1995 she secured Monmbusho scholarship by the Government of Japan. She completed course work in Paediatrics and was enrolled in PhD programme in the University of Shinshu Medical School
She worked with Haematology oncology patients and doing scientific researches patterning to paediatrics malignancies. The topic for her thesis was Quantitative and Qualitative differences in Thrombopoietin-Dependant hematopoietic progenitors development between cord Blood and Bone Marrow concluding that cord blood contains sufficient numbers of hematopoietic progenitors that exhibit high proliferative potential compared to Bone marrow progenitors supporting the use of Cord blood as another source of allogeneic stem cell transplant.
Muhimbili National hospital is in the process of starting Bone marrow transplant. She believes that many African getting such exposure and knowledge and working together in collaboration will improve the care and outcome of childhood cancers and other blood disorders in Africa.
She was a Head of Department of Pediatrics and Childhealth at Muhimbili National Hospital (2009 to 2013). She successfully facilitated the establishment of Paediatric Oncology ward in Muhimbili National Hospital. She revived Paediatric Association of Tanzania (2005) and served as Treasurer to the association (2005- 2013)
She was a Secretary General to the Muhimbili National Hospital Workers Council (2006-2008).
Jonathan Bond Professor of Paediatric Molecular Haemato-oncology and Honorary Consultant Paediatric Haematologist at Children’s Health Ireland (CHI) at CrumlinJonathan BondProfessor of Paediatric Molecular Haemato-oncology and Honorary Consultant Paediatric Haematologist at Children’s Health Ireland (CHI) at Crumlin
Professor Jonathan Bond is the UCD Brendan McGonnell Professor of Paediatric Molecular Haemato-oncology and Honorary Consultant Paediatric Haematologist at Children’s Health Ireland (CHI) at Crumlin. Prof Bond originally trained as a clinical haematologist in Ireland before embarking on a scientific research career in the UK and France at UCL Institute of Child Health, the MRC London Institute of Medical Sciences at Imperial College London and Hôpital Necker-Enfants Malades in Paris.
Prof Bond returned to Ireland in 2018 to lead a new collaborative paediatric leukaemia research programme between the National Children’s Cancer Service at CHI at Crumlin and Systems Biology Ireland at UCD. His group uses systems biology approaches to study the biology of high-risk paediatric blood cancers, with the ultimate aim of finding more precise and effective cures for children and adolescents with these diseases.
Joseph Lubega Pediatric Hematologist-Oncologist at Texas Children’s Hospital and Assistant Professor of Pediatrics at Baylor College of MedicineJoseph LubegaPediatric Hematologist-Oncologist at Texas Children’s Hospital and Assistant Professor of Pediatrics at Baylor College of Medicine
Dr. Joseph Lubega is a Pediatric Hematologist-Oncologist at Texas Children’s Hospital and Assistant Professor of Pediatrics at Baylor College of Medicine.
He is also trained as a molecular epidemiologist and a Certified Physician Executive. He holds several leadership positions focused on his career goal to build capacity for global pediatric hematology-oncology including:
Director of Educational Programs for the Texas Children’s Global (HOPE) Hematology-Oncology Pediatric Excellence;
President of the American Society of Pediatric Hematology-Oncology’s Global Special Interest Group;
Member of the US Pharmacopeia Healthcare Safety & Quality Expert Committee
He was inaugural Director of the Makerere University-Global HOPE Pediatric Hematology-Oncology Fellowship in Uganda, which has trained 14 world-class pediatric oncologists from all over East Africa.
Josephine NjorogeChief Financial Officer, DHL
Josephine is currently the Chief Financial Officer in the DHL (Express) Tanzania office, where she has been working since 2018. She has over the past 11 years, within the DP DHL group, worked in various business units in the finance field on innovative projects such as: design and implementation of a standard KPI model (San Jose, Costa Rica – 2014); Project lead for Sub – Saharan Finance Shared Service Centre (Port Louis, Mauritius – 2018); Digital cashless solutions (Dar es Salaam, Tanzania – 2019).
Josephine is an active member of Tanzania Association of Women Certified Accountants, DHL4Her Country Champion and Women in Leadership (WIL) 2020 candidate. Her passion for public speaking and leadership led her to join the Masaki Executive Toastmasters club. She is a change management enthusiast and believes in sustainably impacting lives through business engagements. She is a certified advanced scuba diver and has recently taken up golfing on weekends.
Lulu ChirandeLecturer, Muhimbili University of Health and Allied Sciences (MUHAS)
Dr. Lulu Chirande is a lecturer at Muhimbili University of Health and Allied Sciences (MUHAS) in the department of Paediatrics and Child Health. She obtained her MMED – Paediatrics and Child health from MUHAS and in 2019 she completed two years fellowship training in Pediatric Haematology and Oncology offered by Makerere University in collaboration with the Global HOPE project of Baylor College of Medicine and Texas Children Hospital.
Dr. Lulu strives to build capacity for care of children with cancer and blood disorders in Tanzania and she believes that centres in Africa should collaborate and engage in multicentre studies to improve outcomes of children with cancer and blood disorders. She is currently working on establishing sub-specialty training in Paediatric Haematology and Oncology at MUHAS to help bridge the human resource gap in her country and in Africa at large.
Mary HorganPresident of the Royal College of Physicians of Ireland
Professor Mary Horgan is the President of the Royal College of Physicians of Ireland. She took up office as the 142nd President in October 2017 and was re-elected for a second three-year term in October 2020. She is the first woman President in RCPI’s 360 year history. Professor Horgan is a Consultant in infectious diseases with Cork University Hospital and Professor, School of Medicine, University College Cork. She is the Chair of National Research Ethics Committee and is a board member of the Health Products Regulatory Authority, Irish Blood Transfusion Service, University College Cork Governing Body, the Cork University Hospital Scientific Advisory Committee, and European Society of Clin Micro & Infectious Disease . She is a Committee Advisor on Return to Sports COVID-19, World Rugby and GAA. Originally from Kerry, Professor Horgan graduated from University College Dublin in 1986. She was awarded her MD in 1995, MRCPI in 1988 and FRCPI in 1997.
Owen Patrick SmithProfessor of Paediatric and Adolescent Medicine at University College Dublin
Owen Smith is Professor of Paediatric and Adolescent Medicine at University College Dublin, Consultant Paediatric Haematologist at Children’s Health Ireland at Crumlin and Chief Academic Lead to the Children Hospital Group. He is the National Clinical Lead for Child, Adolescent & Young Adult cancers at the National Cancer Control Programme. Professor Smith also holds the title, Honorary Regius Professor of Physic (1637) in the School of Medicine, Trinity College Dublin.
The co-author of more than 380 research original articles, letters, books, book chapters and papers, Professor Smith is a Fellow of the Royal College of Paediatrics and Child Health, Royal College of Pathologists, Royal College of Physicians of Dublin, Royal College of Physicians London, Royal College of Physicians Glasgow, and Royal College of Physicians Edinburgh. He is a member of numerous associations and societies, including; the Medical Research Council Childhood Leukaemia Working Party, Children’s Oncology Group [USA], the International Berlin Frankfurt Munster Study Group for Childhood Leukaemia, the United Kingdom Children’s Cancer Group, European Working Group on paediatric aplastic anaemia and myelodysplastic syndromes. He is an international advocate for children and adolescents with rare diseases and for expanded access to expensive drugs.
In 2015 Professor Smith was conferred honorary Commander in the Most Excellent Order of the British Empire (CBE) for his life-long work on cancer in children and adolescents by Queen Elizabeth, on the advice of the Foreign and Commonwealth Office.
Stephen FieldIrish Blood Transfusion Service, Ireland
Born in Kent, Stephen Field emigrated to Southern Rhodesia (now Zimbabwe) at a young age. He was raised and educated in that county. He initially qualified as a medical technologist (now known as Biomedical Scientists) in Clinical Chemistry, Haematology and Blood Transfusion. He then studied medicine at the University of Zimbabwe before emigrating to Johannesburg South Africa where he specialised in Haematology, training in Baragwanath (Soweto), Hillbrow and Johannesburg Hospitals. After qualifying he took charge of the haemophilia clinic and haematology laboratories at the Johannesburg Hospital before being appointed to the post of Deputy Medical Director of the South African Blood Transfusion Service.
In 2003 he returned to the UK and after a short spell at the National Blood Service at Colindale, North London, was appointed Medical Director of the US charity Safe Blood for Africa and was tasked with setting up a demonstration blood service in Abuja Nigeria funded by USAID. With this objective fulfilled he took up a locum post at St Mary’s Hospital in Paddington for seven months before taking up a consultant post at the Welsh Blood Service (WBS).
At the WBS he was initially clinical lead for Apheresis, Transfusion microbiology and the bone marrow registry. He took a keen interest in the blood establishment computer system and led the procurement process of change from Trace to eProgesa. He was appointed Medical Director at WBS in September 2012 and retired from that post in March 2017. He is now the Medical & Scientific Director at IBTS. In February 2019 he was admitted as a Fellow of the Faculty of Pathologists of the Royal College of Physicians of Ireland. He is a Clinical Associate Professor at Trinity College Dublin.